9 ASX 200 shares attracting 'strong buy' ratings from the experts

There is a consensus 'strong buy rating' on these stocks from analysts on the CommSec trading platform.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares rose 2.35% in July and finished the month at 8,742.8 points on Thursday.

The benchmark index closed 0.92% lower yesterday at 8,662 points.

In July, the experts upgraded these nine ASX 200 shares to strong buy ratings.

Let's check them out.

A team of people giving the thumbs up sign.

Image source: Getty Images

9 ASX 200 shares with strong buy ratings

The following ASX 200 shares received an upgraded 'strong buy' consensus rating on the CommSec platform in July.

Telix Pharmaceuticals Ltd (ASX: TLX)

The consensus rating on Telix Pharmaceuticals shares was upgraded to a strong buy on 31 July.

The Telix share price finished the session on Friday at $20.15, down 4.28%.

Bell Potter has a buy rating on this ASX 200 tech share with a 12-month price target of $34.

Worley Ltd (ASX: WOR)

Commsec analysts reached a consensus 'strong buy' rating on Worley shares on 31 July.

The Worley share price closed at $13.38, up 0.22% yesterday.

CSL Ltd (ASX: CSL)

The consensus rating on CSL shares was upgraded to a strong buy on 22 July.

The CSL share price finished last week at $264.05, down 2.53%.

Bell Potter has a buy rating on the ASX 200 healthcare share with a 12-month price target of $305. 

Orica Ltd (ASX: ORI)

Commsec analysts reached a consensus 'strong buy' rating on Orica shares on 22 July.

The Orica share price finished the session on Friday at $21.30, down 0.37%.

UBS has a buy rating on the explosives manufacturer with a 12-month share price target of $32. 

WiseTech Global Ltd (ASX: WTC)

The consensus rating on WiseTech Global shares was upgraded to a strong buy on 22 July.

The WiseTech Global share price finished the session on Friday at $116.34, down 3.04%.

Bell Potter has a buy rating on the ASX 200 tech share and a 12-month target price of $135.

Air New Zealand Ltd (ASX: AIZ)

Commsec analysts reached a consensus 'strong buy' rating on Air New Zealand shares on 31 July.

The ASX 200 airline share closed at $116.34 on Friday, down 2.55%.

But wait, there's more!

Capstone Copper Corp (ASX: CSC)

The consensus rating on Capstone Copper shares was upgraded to a strong buy on 22 July.

Capstone Copper shares led the market on Friday after the miner reported record production.

The ASX 200 copper stock was the fastest riser of the day, up 9.46% to $9.37.

Macquarie has an outperform rating on the ASX 200 copper share with a price target of $13.30. 

Zip Co Ltd (ASX: ZIP)

Commsec analysts reached a consensus 'strong buy' rating on this ASX 200 buy now, pay later stock on 22 July.

The Zip share price finished the week at $3.25, up 0.62%.

Blackwattle portfolio managers Robert Hawkesford and Daniel Broeren said Zip shares still have 'meaningful upside'.

They commented:

We still see meaningful upside through the ongoing penetration of BNPL products in the US which has a significant runway, sitting at only ~2% today, vs ~15% and ~20% in Australia and Europe respectively.

Westgold Resources Ltd (ASX: WGX)

The consensus rating on Westgold Resources shares was upgraded to a strong buy on 22 July.

The Westgold Resources share price closed at $2.53, down 1.17%, yesterday.

Macquarie has an outperform rating on the ASX 200 gold share with a 12-month share price target of $3.60. 

Motley Fool contributor Bronwyn Allen has positions in CSL and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, Telix Pharmaceuticals, WiseTech Global, and Zip Co. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CSL and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three excited business people cheer around a laptop in the office
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A graphic image of a pile of gold coins balanced precariously with a house on top with smoke coming out of the chimney and a human figure with hands up as if to shield himself from the prospect of the house falling.
Broker Notes

This debt collector could surge 47% on negative gearing changes, Shaw and Partners says

A weaker housing market could be a boon for this company.

Read more »

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »